Applied Biosystems Group

Prior to founding VitaPath Genetics, Dennis A. Gilbert was Chief Scientific Officer and Vice President of Research of Applied Biosystems and a Vice President of Applera Corporation. He also directed the Applied Biosystems Advanced Research and Technology (ART) organization, which was responsible for identifying and developing new technologies. Previously, Dr. Gilbert had more than ten years of senior management experience at Applied Biosystems and Celera. Before being named Vice President of Advanced Research and Technology, he held the positions of Vice President, Genomics Applications, Applied Biosystems and Vice President, Gene Discovery, Celera. Prior to joining Applied Biosystems as a research scientist, he was Program Manager, Genetics at W.R. Grace. Dr. Gilbert received a bachelor of science in biochemistry and cell biology from the University of California, San Diego, and his Ph.D. in genetics from Johns Hopkins University, followed by postdoctoral training in population genetics at the National Cancer Institute.

Mr. Tobin has served as President and Chief Executive Officer of Boston Scientific Corporation, a medical device manufacturer, since March 1999. Mr. Tobin previously served as President and Chief Executive Officer of Biogen, Inc., a biotechnology company, from 1997 to 1998 and President and Chief Operating Officer from 1994 to 1997. Prior to joining Biogen, he held various positions at Baxter International Inc., including President and Chief Operating Officer from 1992 to 1994. Mr. Tobin is also a director of Boston Scientific and Curis, Inc.

Arnold J. Levine, Ph.D., is a Professor at The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine and a Professor at the Institute for Advanced Study. From 1998 - 2002, Dr. Levine was President of Rockefeller University. Prior to joining Rockefeller University, Dr. Levine was the Harry C. Weiss Professor in the Life Sciences and Chairman of the Department of Molecular Biology at Princeton University from 1984 - 1996. Dr. Levine also serves as a Director of Theravance, Inc. and Applera Corporation, publicly traded life science companies. Dr. Levine received a B.A. in Biology from Harpur College, State University of New York at Binghamton and a Ph.D. in Microbiology from the University of Pennsylvania.

Dr. Slayman is the Sterling Professor of Genetics and Deputy Dean for Academic and Scientific Affairs at Yale University School of Medicine. She joined the Yale faculty in 1967. Dr. Slayman is a consultant to the National Institutes of Health, most recently having served as a member of the National Advisory General Medical Sciences Council, and a member of the Board of Overseers of Dartmouth Medical School.

Mr. Ayers is the retired Chairman and Chief Executive Officer of The Stanley Works, a tool and hardware manufacturer. He was an advisor to the Chairman and Chief Executive Officer of Stanley from January 1997 to October 1997 after having served as Chairman and Chief Executive Officer of Stanley from May 1989 to December 1996. Mr. Ayers is a Trustee of MassMutual Institutional Funds and MML Series Investment Fund and a director of Instron Corporation.

Array